1-6 of 6
Li Shen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P079: The impact of BCL2 expression on sensitivity to the novel Aurora kinase B inhibitor AZD2811 in small cell lung cancer

Free
Azusa Tanimoto, Carminia M. Della Corte, Kavya Ramkumar, Robert J. Cardnell, Allison C. Stewart, Carl M. Gay, Lauren Averett Byers, Qi Wang, Li Shen, Jing Wang, Jon Travers
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (12_Supplement): P079.
https://doi.org/10.1158/1535-7163.TARG-21-P079
Published: 01 December 2021
View articletitled, Abstract P079: The impact of BCL2 expression on sensitivity to the novel Aurora kinase B inhibitor AZD2811 in small cell lung cancer
Journal Articles

Dual Inhibition of Angiopoietin-TIE2 and MET Alters the Tumor Microenvironment and Prolongs Survival in a Metastatic Model of Renal Cell Carcinoma

Available to Purchase
May Elbanna, Ashley R. Orillion, Nur P. Damayanti, Remi Adelaiye-Ogala, Li Shen, Kiersten Marie Miles, Sreenivasulu Chintala, Eric Ciamporcero, Swathi Ramakrishnan, Sheng-yu Ku, Karen Rex, Sean Caenepeel, Angela Coxon, Roberto Pili
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2020) 19 (1): 147–156.
https://doi.org/10.1158/1535-7163.MCT-18-1202
Published: 03 January 2020
View articletitled, Dual Inhibition of Angiopoietin-TIE2 and MET Alters the Tumor Microenvironment and Prolongs Survival in a Metastatic Model of Renal Cell Carcinoma
Open the PDF for Dual Inhibition of Angiopoietin-TIE2 and MET Alters the Tumor Microenvironment and Prolongs Survival in a Metastatic Model of Renal Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

JAK1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non–Small Cell Lung Cancer

Free
Kazuhiko Shien, Vassiliki A. Papadimitrakopoulou, Dennis Ruder, Carmen Behrens, Li Shen, Neda Kalhor, Juhee Song, J. Jack Lee, Jing Wang, Ximing Tang, Roy S. Herbst, Shinichi Toyooka, Luc Girard, John D. Minna, Jonathan M. Kurie, Ignacio I. Wistuba, Julie G. Izzo
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2017) 16 (10): 2234–2245.
https://doi.org/10.1158/1535-7163.MCT-17-0148
Published: 02 October 2017
View articletitled, JAK1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non–Small Cell Lung Cancer
Open the PDF for JAK1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Sunitinib Dose Escalation Overcomes Transient Resistance in Clear Cell Renal Cell Carcinoma and Is Associated with Epigenetic Modifications

Free
Remi Adelaiye, Eric Ciamporcero, Kiersten Marie Miles, Paula Sotomayor, Jonathan Bard, Maria Tsompana, Dylan Conroy, Li Shen, Swathi Ramakrishnan, Sheng-Yu Ku, Ashley Orillion, Joshua Prey, Gerald Fetterly, Michael Buck, Sreenivasulu Chintala, Georg A. Bjarnason, Roberto Pili
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (2): 513–522.
https://doi.org/10.1158/1535-7163.MCT-14-0208
Published: 09 February 2015
View articletitled, Sunitinib Dose Escalation Overcomes Transient Resistance in Clear Cell Renal Cell Carcinoma and Is Associated with Epigenetic Modifications
Open the PDF for Sunitinib Dose Escalation Overcomes Transient Resistance in Clear Cell Renal Cell Carcinoma and Is Associated with Epigenetic Modifications in another window
Includes: Supplementary data
Journal Articles

Combination Strategy Targeting VEGF and HGF/c-met in Human Renal Cell Carcinoma Models

Free
Eric Ciamporcero, Kiersten Marie Miles, Remi Adelaiye, Swathi Ramakrishnan, Li Shen, ShengYu Ku, Stefania Pizzimenti, Barbara Sennino, Giuseppina Barrera, Roberto Pili
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (1): 101–110.
https://doi.org/10.1158/1535-7163.MCT-14-0094
Published: 13 January 2015
View articletitled, Combination Strategy Targeting VEGF and HGF/c-met in Human Renal Cell Carcinoma Models
Open the PDF for Combination Strategy Targeting VEGF and HGF/c-met in Human Renal Cell Carcinoma Models in another window
Journal Articles

Reversible Epithelial to Mesenchymal Transition and Acquired Resistance to Sunitinib in Patients with Renal Cell Carcinoma: Evidence from a Xenograft Study

Free
Hans J. Hammers, Henk M. Verheul, Brenda Salumbides, Rajni Sharma, Michelle Rudek, Janneke Jaspers, Preeti Shah, Leigh Ellis, Li Shen, Silvia Paesante, Karl Dykema, Kyle Furge, Bin T. Teh, George Netto, Roberto Pili
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (6): 1525–1535.
https://doi.org/10.1158/1535-7163.MCT-09-1106
Published: 09 June 2010
View articletitled, Reversible Epithelial to Mesenchymal Transition and Acquired Resistance to Sunitinib in Patients with Renal Cell Carcinoma: Evidence from a Xenograft Study
Open the PDF for Reversible Epithelial to Mesenchymal Transition and Acquired Resistance to Sunitinib in Patients with Renal Cell Carcinoma: Evidence from a Xenograft Study in another window